Analyst Reco. CSL Limited OTC Markets

Equities

CSLLY

US12637N2045

Delayed OTC Markets Other stock markets 10:05:56 2024-06-20 EDT			5-day change	1st Jan Change
97.12 ^USD	-0.42%		+1.88%	-0.05%

06-18	Bank stocks lift Australian shares ahead of c.bank rate decision	RE
06-11	EU Secures More Than 40 Million Bird Flu Vaccines	DJ

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Morgan Stanley Adjusts CSL’s Price Target to AU$310 From AU$318, Keeps at Overweight	03-05	MT
Jarden Research CSL’s Price Target to AU$296.02 From AU$298.57, Keeps at Overweight	02-13	MT
Jarden Research Adjusts CSL’s Price Target to AU$298.57 From AU$316.16, Keeps at Overweight	02-12	MT
Australian shares hit 1-week high on miners' boost; Fed rate decision in focus	23-06-13	RE
Arcturus Therapeutics Shares Rise 31% After Vaccine Collaboration	22-11-02	DJ
Fitch Withdraws Vifor's Ratings on Acquisition by CSL	22-08-26	AQ
Australia shares flat as miners offset CSL drag, NZ falls ahead of rates decision	22-08-16	RE
Australia shares slump as inflation woes hint at more rate hikes	22-05-06	RE
S&P/ASX 200 : Australian Shares Struggle for Direction Amid Mixed Earnings Results; Unemployment Rate Decreases in January	21-02-18	MT
National Australia Bank : Australia shares wobble ahead of cenbank rate decision; NZ falls	20-08-30	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer